Pacific Biosciences Of California (PACB) Return on Capital Employed (2011 - 2026)

Pacific Biosciences Of California's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 18.57% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 6412.0% year-over-year to 18.57%; the TTM figure through Mar 2026 stood at 18.57% (up 6412.0% YoY), while the FY2025 annual figure was 58.34%, down 2533.0% from the prior year.
• Return on Capital Employed was 18.57% for Q1 2026 at Pacific Biosciences Of California, up from 76.84% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 11.17% in Q1 2022 to a low of 88.63% in Q3 2025.
• Historically, Return on Capital Employed has averaged 35.86% across 5 years, with a median of 20.38% in 2023.
• The sharpest annual moves came in 2025 and 2026: Return on Capital Employed slumped 6283 bps in 2025, then jumped 6412 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 20.08% in 2022, then climbed by 4 bps to 19.37% in 2023, then tumbled by 90 bps to 36.8% in 2024, then slumped by 109 bps to 76.84% in 2025, then soared by 76 bps to 18.57% in 2026.
• The last three Return on Capital Employed figures came in at 18.57% (Q1 2026), 76.84% (Q4 2025), and 88.63% (Q3 2025), per Business Quant data.